EB-2 NIW Opportunities for Medical and Mental Health Research Professionals in the U.S. 

The United States is accelerating research into new treatments for serious mental illness, and federal policy stands behind that effort. The April 18, 2026 Executive Order “Accelerating Medical Treatments for Serious Mental Illness” directs federal agencies to speed up research, regulatory review, and patient access to promising mental health therapies.  

Mental health researchers, physicians, pharmacologists, and other professionals can connect their work to this recognized national priority to strengthen an EB-2 National Interest Waiver (NIW) petition.  The EB-2 NIW waives the standard job offer and PERM labor certification requirements when the work is in the national interest, which allows the applicant to self-petition their green card. For professionals in medicine and mental health research, the April 2026 Executive Order provides direct policy support for that argument.  

See If You Qualify

Get Your Free EB-2 NIW Visa Profile Evaluation

Evaluate my Profile

What the Executive Order on Mental Health Research Means for EB-2 NIW Petitions 

When evaluating EB-2 NIW petitions, USCIS considers whether the proposed work aligns with national priorities or areas of demonstrated government interest. Executive orders are particularly significant because they formally establish federal policy direction and highlight issues the government has identified as requiring accelerated progress. As a result, work related to serious mental illness has direct support for the national importance element of an EB-2 NIW petition.  

The April 2026 Executive Order sets out several federal priorities. The order directs the Food and Drug Administration (FDA) to prioritize review of certain psychedelic drugs that have earned Breakthrough Therapy designation, a status that speeds up the regulatory pathway. The order also opens patient access routes under the Right to Try Act, a federal law that allows eligible patients with life-threatening conditions to seek access to certain investigational treatments outside of clinical trials, and calls for the review and rescheduling of qualifying treatments once they clear clinical trials. 

The order backs these goals with resources. The Department of Health and Human Services (HHS) will allocate at least $50 million to partner with state programs advancing this research. The order also directs HHS, the FDA, and the Department of Veterans Affairs (VA) to share data and expand clinical trial participation, with veterans named as a priority population. 

For foreign national professionals, the value lies in what the order signals. When the federal government names a particular research area as a national priority, that recognition strengthens the national importance element of an EB-2 NIW petition. A petitioner must show that a proposed endeavor has both substantial merit and national importance, and a current Executive Order is strong evidence that the work matters on a national scale. 

Connecting Mental Health Research Contributions to Federal Priorities  

The Executive Order points to clear national priorities that mental health professionals can connect their work to when preparing an EB-2 NIW petition. The order targets faster research and regulatory review for promising treatments for serious mental illness, including therapies already moving through the clinical trial pipeline. It also prioritizes expanding patient access through Right to Try pathways, building federal and state funding partnerships to advance the research, and improving mental health care for veterans, a population the order names specifically. 

For professionals in medicine and mental health, these priorities translate into a range of natural connections to everyday work. Conducting or supporting clinical research on new treatments fits directly. So does developing psychiatric treatments, drug therapies, or care models that improve patient outcomes, contributing to clinical trials and data sharing that move treatments toward approval, and advancing mental health care for veterans and other underserved populations. 

The connection does not require direct work on psychedelic drugs and is not limited to medical or scientific professions. This order reflects a broad federal interest in improving mental health at a national scale. The deciding question is whether a person’s work advances that goal, not the field they come from. This means that while researchers, clinicians, and public health professionals fit naturally, so can professionals from technology, data, social services, and other fields whose work supports mental health care. 

EB-2 NIW Approvals for Professionals in Mental Health and Medical Research

Colombo & Hurd has secured a number of EB-2 NIW approvals for professionals in mental health and medical research. The cases below show how each petition connected that work to the national interest of the United States.  

Mental Health Counselor 

Our client built his career around a single conviction: that vulnerable young people, given the right support, can finish school and step into futures once thought out of reach. Over two decades, he developed a model that pairs trauma-responsive counseling with career readiness programming, reaching hundreds of adolescents and producing measurable outcomes including higher school re-enrollment and fewer behavioral crises. The petition connected those local results to federal priorities around youth mental health, demonstrating that his model was not a community program but a replicable framework other schools and districts could adopt nationwide. His EB-2 NIW petition was approved. 

Clinical Social Worker 

Our client came to the United States to address a gap that affects millions of people: the shortage of comprehensive mental healthcare and social services for diverse populations. Her proposed model focuses on clinical intervention, health equity, and reducing the disparities that leave underserved communities without adequate support. The petition demonstrated that her work addressed a systemic national need extending well beyond any single community or patient group. Her EB-2 NIW approval came in five months and eight days. 

School Psychologist 

Our client dedicated more than 15 years to designing and implementing psycho-educational programs for students with disabilities, addressing mental health, inclusion, and the discrimination these students routinely face. Her work aligned directly with longstanding federal protections under the Americans with Disabilities Act and with national priorities around mental health support in educational settings. Her EB-2 NIW approval came in less than three months after filing. 

Early Childhood Mental Health Specialist 

Our client proposed a comprehensive early intervention program for preschool and school-aged children, designed to identify risk factors before they compound, promote emotional well-being, and build the social-emotional skills children need to thrive. The model was built for scale, with implementation pathways across schools, community centers, and mental health clinics serving diverse populations across the United States. 

Frequently Asked Questions  

How does the Executive Order on mental health treatments relate to the EB-2 NIW? 

The order names accelerating mental health research and treatment a federal priority. EB-2 NIW petitioners can cite it as evidence that their work addresses a matter of national importance, which supports the first prong of the EB-2 NIW standard. 

Which professionals can strengthen their EB-2 NIW arguments under this Executive Order?   

A wide range of professionals can benefit from this Executive Order. Doctors, researchers, pharmacologists, and clinicians fit most directly, and professionals in other fields, such as technology, data, and social services, may also qualify when their work advances mental health. The deciding factor is whether the proposed endeavor has substantial merit and national importance, not the field it comes from. 

Do I have to work on psychedelic drugs to use this Executive Order for an EB-2 NIW?  

No. The order focuses on psychedelic treatments, but it also reflects a broader federal priority on mental health. Professionals whose work improves mental health in other ways can still point to it as evidence of national importance. 

See If You Qualify

Get Your Free EB-2 NIW Visa Profile Evaluation

Evaluate My Profile